---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-074032"
form_type: "8-K"
ticker: "CRBP"
cik: "0001595097"
company_name: "Corbus Pharmaceuticals Holdings, Inc."
filed_at: "2024-06-17T23:59:59+00:00"
generated_at: "2026-06-01T04:06:33.322579+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Corbus board member Dr. Yong Ben adopts 10b5-1 plan for up to 10,607 shares

## Summary
- Dr. Yong Ben, a board member, adopted a Rule 10b5-1 trading plan on June 14, 2024.
- Plan authorizes sale of up to 10,607 shares of CRBP common stock.
- Sales may begin September 12, 2024; plan terminates September 11, 2025.
- Plan is intended to satisfy affirmative defense under Rule 10b5-1(c).

## SEC filing metadata
- accession: 0000950170-24-074032
- form_type: 8-K
- ticker: CRBP
- cik: 0001595097
- company_name: Corbus Pharmaceuticals Holdings, Inc.
- filed_at: 2024-06-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1595097/000095017024074032/0000950170-24-074032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1595097/000095017024074032/crbp-20240614.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-074032
- JSON: https://secwatch.observer/filing/0000950170-24-074032.json
- Plain text: https://secwatch.observer/filing/0000950170-24-074032.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.